Theca Lutein Cells represent a distinctive type of cells that emerge during the luteal phase of the menstrual cycle or in the corpus luteum of pregnancy. Originating from the theca interna cells surrounding the developing ovarian follicle, theca lutein cells undergo transformations under the influence of luteinizing hormone (LH). These cells play a crucial role in the production of progesterone, a hormone vital for maintaining pregnancy. Theca lutein cells, along with granulosa lutein cells, constitute the corpus luteum, a temporary endocrine structure formed after ovulation. Progesterone produced by theca lutein cells helps prepare the endometrium for potential embryo implantation and maintains a supportive environment for early pregnancy. In conditions such as gestational trophoblastic disease, ovarian hyperstimulation syndrome, or multiple pregnancies, the ovaries can develop multiple corpora lutea, leading to an excessive production of progesterone and its metabolites. Understanding the functions of theca lutein cells is crucial for comprehending reproductive physiology and addressing conditions related to hormonal imbalances. Research in this area contributes to advancements in reproductive medicine, fertility treatments, and the management of disorders affecting the corpus luteum. Ongoing studies aim to uncover the molecular mechanisms governing theca lutein cell function and their impact on reproductive health.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States